PL117603B1 - Process for preparing novel derivatives of oleandomycin,erythromycin a or b,erythromyciloamine or erythromycin carbonateitromicina a ili b,ehfitromiciloamina ili karbonata ehritromicina - Google Patents

Process for preparing novel derivatives of oleandomycin,erythromycin a or b,erythromyciloamine or erythromycin carbonateitromicina a ili b,ehfitromiciloamina ili karbonata ehritromicina Download PDF

Info

Publication number
PL117603B1
PL117603B1 PL1979212593A PL21259379A PL117603B1 PL 117603 B1 PL117603 B1 PL 117603B1 PL 1979212593 A PL1979212593 A PL 1979212593A PL 21259379 A PL21259379 A PL 21259379A PL 117603 B1 PL117603 B1 PL 117603B1
Authority
PL
Poland
Prior art keywords
formula
acid
erythromycin
group
mixture
Prior art date
Application number
PL1979212593A
Other languages
English (en)
Polish (pl)
Other versions
PL212593A1 (pl
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PL212593A1 publication Critical patent/PL212593A1/xx
Publication of PL117603B1 publication Critical patent/PL117603B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL1979212593A 1978-01-03 1979-01-03 Process for preparing novel derivatives of oleandomycin,erythromycin a or b,erythromyciloamine or erythromycin carbonateitromicina a ili b,ehfitromiciloamina ili karbonata ehritromicina PL117603B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86672278A 1978-01-03 1978-01-03
US05/937,640 US4180654A (en) 1978-01-03 1978-08-29 4"-Deoxy-4"-acylamido derivatives of oleandomycin, erythromycin and erythromycin carbonate

Publications (2)

Publication Number Publication Date
PL212593A1 PL212593A1 (pl) 1979-08-27
PL117603B1 true PL117603B1 (en) 1981-08-31

Family

ID=27127966

Family Applications (2)

Application Number Title Priority Date Filing Date
PL1979212593A PL117603B1 (en) 1978-01-03 1979-01-03 Process for preparing novel derivatives of oleandomycin,erythromycin a or b,erythromyciloamine or erythromycin carbonateitromicina a ili b,ehfitromiciloamina ili karbonata ehritromicina
PL1979227812A PL118573B1 (en) 1978-01-03 1979-01-03 Process for preparing novel derivatives of oleandomycin,erythromycin a or b,erythromycyloamine or erythromycin carbonateitromiciny a ili b,ehritromicilamina ili karbonata ehritromicina

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL1979227812A PL118573B1 (en) 1978-01-03 1979-01-03 Process for preparing novel derivatives of oleandomycin,erythromycin a or b,erythromycyloamine or erythromycin carbonateitromiciny a ili b,ehritromicilamina ili karbonata ehritromicina

Country Status (28)

Country Link
US (1) US4180654A (en, 2012)
JP (1) JPS5495585A (en, 2012)
AT (1) AT364457B (en, 2012)
AU (1) AU506684B2 (en, 2012)
CH (1) CH639972A5 (en, 2012)
CS (1) CS204042B2 (en, 2012)
DD (1) DD141026A5 (en, 2012)
DE (2) DE2953969C2 (en, 2012)
DK (1) DK147943C (en, 2012)
ES (2) ES476544A1 (en, 2012)
FI (1) FI68058C (en, 2012)
FR (1) FR2413403A1 (en, 2012)
GB (1) GB2013181B (en, 2012)
GR (1) GR72779B (en, 2012)
HU (1) HU180276B (en, 2012)
IE (1) IE47642B1 (en, 2012)
IL (1) IL56363A (en, 2012)
IN (1) IN150395B (en, 2012)
IT (1) IT1109925B (en, 2012)
LU (1) LU80747A1 (en, 2012)
NL (1) NL176461C (en, 2012)
NO (2) NO146711C (en, 2012)
NZ (1) NZ189274A (en, 2012)
PH (4) PH14745A (en, 2012)
PL (2) PL117603B1 (en, 2012)
PT (1) PT69014A (en, 2012)
SE (2) SE447118B (en, 2012)
YU (2) YU312278A (en, 2012)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5848285U (ja) * 1981-09-26 1983-04-01 コナミ工業株式会社 テ−ブル型テレビゲ−ム機
US4429116A (en) * 1982-12-27 1984-01-31 Pfizer Inc. Alkylated oleandomycin containing compounds
US4518590A (en) * 1984-04-13 1985-05-21 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
JPS62240086A (ja) * 1986-04-12 1987-10-20 株式会社 エ−ス電研 遊技機の前面構造
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
YU55690A (en) * 1990-03-21 1990-12-31 Pliva Pharm & Chem Works Process for preparing oleandomycin oxime
GB0310980D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
WO2004101587A1 (en) * 2003-05-13 2004-11-25 Glaxo Group Limited Novel 14 and 15 memberred-ring compounds
GB0310992D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869445A (en) * 1973-05-03 1975-03-04 Abbott Lab 4{41 -O-sulfonyl erythromycin-9-O-oxime derivatives
US3884902A (en) * 1973-05-04 1975-05-20 Abbott Lab Sulfonyl derivatives of erythromycin
US3884903A (en) * 1973-06-21 1975-05-20 Abbott Lab 4{41 -Deoxy-4{41 -oxoerythromycin B derivatives
US4063014A (en) * 1975-06-12 1977-12-13 Abbott Laboratories 4"-O-sulfonyl erythromycin-9-O-oxime derivatives
US4069379A (en) * 1976-07-08 1978-01-17 Pfizer Inc. Semi-synthetic oleandomycins
IE44509B1 (en) * 1976-03-03 1981-12-30 Pfizer Semi-synthetic oleandomycins
US4085119A (en) * 1977-02-04 1978-04-18 Pfizer Inc. 4-Substituted amino derivatives of oleandomycin
US4090017A (en) * 1977-02-04 1978-05-16 Pfizer Inc. 4-Deoxy-4-substituted amino derivatives of oleandomycin

Also Published As

Publication number Publication date
NL176461C (nl) 1985-04-16
FR2413403A1 (fr) 1979-07-27
FI68058B (fi) 1985-03-29
NL7900006A (nl) 1979-07-05
PH14745A (en) 1981-11-20
DD141026A5 (de) 1980-04-09
DE2953969C2 (en, 2012) 1987-09-03
IL56363A (en) 1982-12-31
NO147716B (no) 1983-02-21
NO790006L (no) 1979-07-04
LU80747A1 (fr) 1979-09-07
YU312278A (en) 1983-01-21
PH15626A (en) 1983-03-11
NO820613L (no) 1979-07-04
IE790005L (en) 1979-07-03
YU213982A (en) 1983-02-28
AT364457B (de) 1981-10-27
AU506684B2 (en) 1980-01-17
DK147943B (da) 1985-01-14
FI790004A7 (fi) 1979-07-04
GB2013181B (en) 1982-06-03
IE47642B1 (en) 1984-05-16
AU4298578A (en) 1979-07-12
HU180276B (en) 1983-02-28
ES482420A1 (es) 1980-09-01
JPS5495585A (en) 1979-07-28
ATA2979A (de) 1981-03-15
PH15439A (en) 1983-01-18
PL212593A1 (pl) 1979-08-27
SE8304417L (sv) 1983-08-15
PL118573B1 (en) 1981-10-31
PT69014A (en) 1979-02-01
IT1109925B (it) 1985-12-23
DK507778A (da) 1979-07-04
CS204042B2 (en) 1981-03-31
IL56363A0 (en) 1979-03-12
JPS5734280B2 (en, 2012) 1982-07-22
IT7919013A0 (it) 1979-01-02
NZ189274A (en) 1982-03-23
ES476544A1 (es) 1979-12-01
US4180654A (en) 1979-12-25
IN150395B (en, 2012) 1982-09-25
DE2900118A1 (de) 1979-07-05
DK147943C (da) 1985-08-05
FI68058C (fi) 1985-07-10
GR72779B (en, 2012) 1983-12-05
NO147716C (no) 1983-06-01
SE447118B (sv) 1986-10-27
FR2413403B1 (en, 2012) 1982-07-23
NO146711C (no) 1982-11-24
PH15752A (en) 1983-03-18
DE2900118C2 (en, 2012) 1987-09-17
NO146711B (no) 1982-08-16
SE7900028L (sv) 1979-07-04
SE8304417D0 (sv) 1983-08-15
CH639972A5 (de) 1983-12-15
GB2013181A (en) 1979-08-08
SE448385B (sv) 1987-02-16

Similar Documents

Publication Publication Date Title
Kassem et al. Synthesis and anticancer activity of new ((Furan-2-yl)-1, 3, 4-thiadiazolyl)-1, 3, 4-oxadiazole acyclic sugar derivatives
RU2126416C1 (ru) Производные эритромицина, фармацевтическая композиция на их основе, способ их получения и промежуточные соединения
RU2114859C1 (ru) Производные эритромицина, фармацевтическая композиция, способ получения производных эритромицина
HK586A (en) Oximes derived from erythromycin a, their preparation, their application in pharmaceuticals and pharmaceutical compositions containing them
EP0638585A1 (en) 5-o-desosaminylerythronolide a derivative
PL117603B1 (en) Process for preparing novel derivatives of oleandomycin,erythromycin a or b,erythromyciloamine or erythromycin carbonateitromicina a ili b,ehfitromiciloamina ili karbonata ehritromicina
KR850000965B1 (ko) 4"-에피 에리스로마이신 a 및 그의 유도체의 제조방법
Christina et al. Multigram-scale synthesis of an orthogonally protected 2-acetamido-4-amino-2, 4, 6-trideoxy-D-galactose (AAT) building block
DE69400817T2 (de) 9a-N-(N'-Carbamoyl)-und 9a-N-(N'Thiocarbamoyl)-Derivate von 9-Deoxo-9a-aza-9a-homoerythromycin A
EP2460810B1 (en) Novel flavanone derivative
US4156777A (en) Process for producing glucopyranose-nitrosourea compounds and novel compounds included therein
BRPI0908343A2 (pt) macrolídeos e seu uso
Shusheng et al. Simple and efficient synthesis of novel glycosyl thiourea derivatives as potential antitumor agents
SU1054352A1 (ru) N-гликозиловые производные даунорубицина,про вл ющие антибиотическую активность
US4935504A (en) Epipodophyllotoxin glucoside 4'-acyl derivatives
DE3888529T2 (de) Tylosinderivate und Verfahren zu ihrer Herstellung.
NO145843B (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme n1-glukofuranosid-6-yl-n3-nitroso-urinstoffer
EP0234348B1 (de) Neue N-Glycosylamidderivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
CZ414998A3 (cs) Nové glykosidy s antikoagulačním účinkem a z nich připravené farmaceutické kompozice
DE3689036T2 (de) Lankacidinderivate und ihre Herstellung.
FR2808797A1 (fr) Nouveaux derives de l'uridine, leur procede de preparation et leur application comme medicaments
CA2372977A1 (en) Halo derivatives of 9-deoxo-9a-aza-9a-homerythromycin a
SK283715B6 (sk) Deriváty erytromycínu, spôsob a medziprodukty na ich prípravu, ich použitie ako liečiv a farmaceutické kompozície s ich obsahom
US4166901A (en) 4"-Deoxy-4"-arylglyoxamido- and aroylthioformamido derivatives of oleandomycin and its esters
AU726147B2 (en) New derivatives of erythromycin, a method for preparing them, and their use as medicines